Table 3. Summary of Selected Publications .

Author(s)	Year of Publication	Origin/ Country	Aims/Purpose	Type of Publication	Key Findings
James C. Robinson (10)	2008	USA	Applies the core principles of value-based purchasing To the medical device market		Core principles of value-based purchasing are integrated data on price and performance; alignment of financial incentives; and organizational capability to evaluate alternatives.
Christopher D. Provines (20)	2010	USA	To explore organizational barriers of value-based pricing.	Review	A better understanding of value will help lead to better investment decisions for the company and a better spending of our scarce health-care dollars as a society.
Corinna Sorenson, Panos Kanavosa (6)	2011	EU	To discuss the procurement of select medical devices across five countries	Review	A general theme across all national procurement systems was a focus on cost-containment
Wi lliam T. Obremskey, Teresa Dail, A. Alex Jahangir (16)	2012	USA	We describe the challenges, implementation, and outcomes of cost reduction and product stabilization of a value-based process for purchasing medical devices	Case study	The implementation of a facility-based technology assessment committee that critically evaluates new technology can decrease hospital costs on implants and standardize some product lines
Chris Henshall Tara Schuller (18)	2013	UK	Describes some of the key themes from The Health Technology Assessment International Policy Forum	Round tables summaries	Most decision-making systems seek to take account of similar elements of value, although they are assessed and combined in different ways
Gerecke G, Clawson J, Verboven Y (2)	2015	EU	To address healthcare challenges and present new framework based on new EU directive	Report
Corinna Sorenson, Michael Drummond, Lawton R. Burns (21)	2015	-	Examines medical device reimbursement and pricing policies in the United States and Europe, with a particular focus on value	Review	Compared to the United States, Europe more formally and consistently considers value to determine which technologies to cover and at what price, especially for complex, costly devices
Nicolas Martell i, Paul Hansen, Hélène van den Brink, Aurélie Boudard, Anne-Laure Cordonnier, Capucine Devaux, Judith Pineau, Patrice Prognon, Isabelle Borget (22)	2015	France	To develop a funding decision-support tool combining MCDA and mini-HTA,	Survey	The tool could help to promote a more structured and transparent approach to HTA decision-making
Gabriela Prada (15)	2016	Canada	This article presents an overview of value within healthcare systems and how healthcare value-based procurement is being implemented across various jurisdictions in Canada.	Round tables summaries	Strategic, value-based procurement can be a powerful tool to reinvent the future of healthcare.
Caroline Mosessian (23)	2016	USA	Examines the extent to which Value Based Purchasing is being used to purchase implanted orthopedic medical devices	Survey	Decisions are commonly, made by committees and process is still mostly based on information derived from the clinical experience of clinicians and local knowledge of procurement officers, with less influence from more formalized health technology assessments
Andrea Messori, Sabrina Trippoli, Claudio Marinai (5)	2017	UK	To investigate the cost-utility profile of prostheses for hip replacement and to calculate a value-based score to be used in the process of procurement and tendering for these devices.	HTA	The incorporation of value-based criteria in the procurement process can contribute to optimizing the value for money for THA devices
Andrea Messori, Sabrina Trippoli (12)	2017	-	This study explored how pharmacoeconomic models can inform the procurement of TKA devices to improve their value for money.	HTA	Results showed that incorporating the principles of cost-effectiveness into the tendering process is feasible for devices.
Joanne M eehan, Laura Menzies, Roula Michaelides (13)	2017	UK	To adopt the resource-based view (RBV) as a lens to explore the extent to which NHS resources support the strategic adoption of value-based approaches	Empirical case study	In public procurement environments, the significant legitimizing impact of the policy environment can effectively block the progression to more sustainable procurement approaches, and requires consideration if procurement is to contribute strategically.
Heidi Krantz, BSN,a Barba ra Strain, Jane Torzewski (24)	2017	USA	To assess value analysis process in procurement of Medical device innovation	Case study	Consideration of the degree to which the product or a potentially new innovative idea improves patient care and patient satisfaction is also part of the decision-making process, but other financial concerns and a value-based analysis do and will play an important part in this decision.
Sabrina Trippoli, Erminia Caccese, Claudio Marinai, Andrea Messori (9)	2018	Italy	To explored using pharmacoeconomic models in the in-hospital procurement of thrombectomy devices.	HTA	Bridging the methodology of cost-effectiveness with the every-day practice of in-hospital procurement can contribute to maximizing the health returns that are generated by in-hospital expenditures for medical devices.
Kull S, Atanasov P, Jonas N (14)	2018	EU	To assess the impact of evidence-focused policy changes on the availability of clinical evidence for medical devices and their use in purchasing.	Structured review of clinical trials	Across all EU countries, the median use of MEAT vs. lowest price tender award criteria increased from 49% before to 69% after 2014.
Bruce Campbell Mark Campbell Lee Dobson Joanne Higgins Bernice Dillon Mirella Marlow (25)	2018	UK	To have a detailed scrutiny of claims made for the benefits of products and the corresponding evidence	Documents review	It illustrates the importance of relevant evidence and of having a clear vision of the place of new products in care pathways from an early stage
Federico Pennestrì, Giuseppe Lippi, Giuseppe Banfi (11)	2019	Italy	To introduce VBP from a theoretical and an empirical level, referring to relevant practices and challenges which emerged in the current institutional, clinical and academic debate	Review	When different dimensions of value are supported by well-designed study to identify the respective outcomes, it becomes easier to find better solutions in support of healthcare quality and sustainability
Fiona A. Miller, P ascale Lehoux, Stuart Peacock, Valeria E. Rac, Jeff Neukomm, Carolyn Barg, Jessica P. Bytautas and Murray Krahn (4)	2019	Canada	To have detailed analysis of how procurement approaches the decision task	Document review	While aiming to go beyond price in the acquisition of most medical technologies, it adopts a narrow approach to assessing quality and costs, but also attends to factors little considered by HTA